Olfactory phenotypic expression unveils human aging by Mazzatenta, Andrea et al.
Oncotarget1www.impactjournals.com/oncotarget
www.impactjournals.com/oncotarget/ Oncotarget, Advance Publications 2016
Olfactory phenotypic expression unveils human aging
Mazzatenta Andrea1,*, Cellerino Alessandro2, Origlia Nicola3, Barloscio Davide3,4, 
Sartucci Ferdinando4, Di Giulio Camillo1 and Domenici Luciano3,5
1 Department of Neuroscience, Imaging and Clinical Science, ‘G. d’Annunzio’ University of Chieti-Pescara, Chieti, Italy
2 Scuola Normale Superiore, Pisa, Italy
3 Neuroscience Institute, CNR-Pisa, Italy
4 Azienda Ospedaliero-Universitaria Pisana, DAI di Neuroscienze, S.D. di Neurofisiopatologia Ospedale Cisanello, Pisa, Italy
5 Department of Applied Clinical Science and Biotechnology (DISCAB), School of Medicine, l’Aquila University, L’Aquila, Italy
Correspondence to: Andrea Mazzatenta, email: : amazzatenta@yahoo.com
Keywords: aging, olfaction, olfactometry, absolute threshold, olfactory phenotype
Received: March 01, 2016 Accepted: March 18, 2016 Published: 
ABSTRACT
The mechanism of the natural aging of olfaction and its decline in the absence of 
any overt disease conditions remains unclear. Here, we investigated this mechanism 
through measurement of one of the parameters of olfactory function, the absolute 
threshold, in a healthy population from childhood to old age. The absolute olfactory 
threshold data were collected from an Italian observational study with 622 participants 
aged 5-105 years. A subjective testing procedure of constant stimuli was used, which 
was also compared to the ‘staircase’ method, with the calculation of the reliability. The 
n-butanol stimulus was used as an ascending series of nine molar concentrations that 
were monitored using an electronic nose. The data were analyzed using nonparametric 
statistics because of the multimodal distribution. We show that the age-related 
variations in the absolute olfactory threshold are not continuous; instead, there are 
multiple olfactory phenotypes. Three distinct age-related phenotypes were defined, 
termed as ‘juvenile’, ‘mature’ and ‘elder’. The frequency of these three phenotypes 
depends on age. Our data suggest that the sense of smell does not decrease linearly 
with aging. Our findings provide the basis for further understanding of olfactory loss 
as an anticipatory sign of aging and neurodegenerative processes.
INTRODUCTION
Olfaction, or the sense of smell, is devoted to 
the capture of the infinite molecular diversity of the 
environment, to extract vital information through the 
generation of individual perceptions [1] that relate to food, 
in particular, and to our surroundings and relationships. 
Functional impairment of olfaction has a negative impact 
on quality of life, and on health and socioeconomic 
consequences. Olfaction is a chemosensory processing 
system that can detect potentially infinite numbers of low-
molecular-mass compounds, known as odorants, which 
combine at different concentrations to elicit this complex 
perception. 
Recently, there has been discussion around the 
magnitude of olfaction and its subjective capabilities. 
In addressing these questions, the lower limit of human 
olfactory discrimination has been increased to more than 
one ‘trillion’ (1012) odors [1]. Furthermore, the existence 
of an individual olfactory fingerprint has been clarified, 
and this relates to the expression of a unique subset of 
the repertoire of olfactory receptors that appears to be 
genetically related to human leukocyte antigen [2]. 
Despite these breakthroughs, the question of how olfaction 
fluctuates over time remains largely unanswered, and in 
particular, the process of natural aging of olfaction and 
its decline in the absence of any overt disease conditions 
[3-5].
To define this process of natural aging and the 
decline of olfaction, we measured one of the olfactory 
functional parameters across the full spectrum from 
children to the elderly. As the olfactory function is 
structured in a multidimensional stimulating/ perceptual 
space, its evaluation is feasible through its disassembly 
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into its principal physiological components, in terms of 
its sensory threshold, discrimination, and identification 
[6, 7]. Here we measured the absolute olfactory threshold 
as defined by Doty and Laing [8], as “the lowest odorant 
concentration where the faint presence of an odor is 
distinguished”.
We show here that the age-related variations in the 
absolute olfactory threshold are not continuous; instead, 
there are multiple olfactory phenotypes. Three distinct 
age-related phenotypes are defined, which we have termed 
the ‘juvenile’, ‘mature’ and ‘elder’ olfactory phenotypes.
RESULTS
Absolute olfactory threshold evaluation
The absolute olfactory threshold is the lowest 
odorant concentration at which the presence of an odor can 
be distinguished [8]. This threshold was measured here 
by olfactory testing on a healthy population (n = 622; age 
range, 5-105 years). We also reduced the chemo-physical 
variability by using an electronic nose device (e-nose) 
to measure the differences (∆) between the measured 
quantitative curves of the volatilized reference material 
and the respective stimulation solutions in real time 
(Figure 1). This represents the most important bias that 
is often ignored in olfactory psychophysiological testing. 
Figure 1: Comparison between n-butanol concentrations (ppm) in a solution series (gray circle) and its volatilized 
concentration measured by the e-nose (iAQ-2000; ppm) (black squares). The differences (Δ) between the concentrations (ppm) 
in the solution series and their volatilized fraction from #1 to #9 were: 71.7%; 77.6%; 77.5%; 91.4%; 93.3%; 94.5%; 95.4%; 96.2%; 96.4%. 
The overall mean Δ was 88.2% ±9.7 SD. The Δ highlights a tremendous bias, which is independent of the method or the reference material. 
By measuring the exact amount of the volatilized n-butanol from the stimulating solution, the absolute olfactory threshold was referred to 
the real stimulus concentration that reached the nose. The experiments, e-nose recordings, and testing were performed under controlled 
conditions, with the temperature kept at 23 °C.
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The reference material applied was that which is in widest 
use, n-butanol [8, 9, 14], and its dilutions (see Methods). 
To provide an experimental basis for the method 
of olfactory perception used here, we initially compared 
the two most used methods, as those of constant and 
‘staircase’ stimuli [8]. When these were compared across 
a randomly selected subgroup (n = 20; equally distributed 
according to gender), no significant differences emerged 
(F
(1,18)
 = 0.43; p = 0.51). Thus, the choice here was to use 
the standard method of constant stimulus, to avoid the 
other potential bias that can arise from the physiological 
mechanism of adaptation.
In addition, we performed another control, as 
indicated by Doty et al. [13]: the test was repeated with 
a further random subgroup (n = 20), to calculate the 
reliability coefficient (0.82). Here, repeated measure 
ANOVA revealed no significant main effects for the 
factors of ‘test/ re-test’ (F
(1,18)
 = 0.39, p = 0.54) and 
‘gender’ (F
(1,18)
 = 0.64, p = 0.44), nor did these show any 
significant interactions (F
(2,38)
 = 0.005, p = 0.94).
Absolute olfactory threshold phenotyping
To define the progression of the absolute olfactory 
threshold through the human life span, the data were 
clustered into age decade classes (Figure 2), according 
to similar methods reported in the literature [8, 13]. 
This demonstrated that the sense of smell as assessed 
by this determination of the absolute olfactory threshold 
progressively declined with age (Figure 2). This 
absolute olfactory threshold did not show a unimodal 
distribution (Kolmogorov-Smirnov normality test, p = 
0.17), but instead showed a multiple peak distribution, 
which discriminated three age-related phenotypes (non-
parametric Kruscal-Wallis test, α = 0.05, Chi-square 
= 531.2). Consequently, these groups were termed 
‘juvenile’, from the initial n-butanol dilution #1 up 
to #3.4; ‘mature’, from #3.5 up to #5.9; and ‘elder’, as 
greater than #6 (Figure 3). There were no statistically 
significant differences between the sexes (non-parametric 
Kruscal-Wallis test, α = 0.05, Chi-square = 2.4), with both 
expressing the three phenotypes.
Figure 2: Variation in the absolute olfactory threshold aging. Relationship between the constant n-butanol ascending series (see 
Figure 1) and the cluster ages per decade: 10 (n = 18); 20 (n = 291); 30 (n = 127); 40 (n = 39); 50 (n = 55); 60 (n = 47); 70 (n = 29); > 80 
(n = 16). Data are means ±standard deviation. The mean score shift increased within aging, which corresponds to a decrease in the absolute 
olfactory threshold.
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Absolute olfactory threshold aging
A further aspect defined here is that the absolute 
olfactory threshold declined with aging, as follows: 
the proportion of subjects with the juvenile phenotype 
decreased almost linearly through life, with a mirror 
increase in the elder phenotype. Instead, the proportion of 
subjects with the mature phenotype showed a bell-shaped 
curve, with the peak in the 50-year-old age cluster (Figure 
4). 
The frequencies of these three different olfactory 
phenotypes (i.e., juvenile, mature, elder) depend on age, 
as about 60% of the subjects lost their juvenile phenotype 
within the third decade of life, with its preservation to 
an elderly age in about 30% (Figure 4, see black line). 
Conversely, during this lifespan segment, about 25% of 
the total subjects developed the mature and elder olfactory 
phenotypes (Figure 4, see grey lines).
DISCUSSION
This analysis shows that age-related variations in the 
absolute olfactory threshold are not continuous; instead, 
there are multiple olfactory phenotypes, a situation that has 
not been described previously. These data thus define three 
distinct age-related phenotypes, which we have termed the 
‘juvenile’, ‘mature’ and ‘elder’ olfactory phenotypes.
We investigated here the absolute olfactory 
threshold for an odorant, namely n-butanol. The basis for 
the choice of any specific odorant, including n-butanol 
[15, 16], can be debated for a number of reasons, such 
as variability in the chemical and physical nature, 
concentrations used, subjective anosmia or dysosmia, 
and cross-modal stimulation. The e-nose measures as 
applied here removed the physicochemical factors that 
affect odorant volatility, thus reducing the experimental 
variability for the determination of the absolute olfactory 
threshold.
The first main result here is that absolute olfactory 
threshold decay does not show a unimodal distribution, 
but instead shows a multiple peak distribution, which 
highlighted the three age-related phenotypes, as juvenile, 
mature and elder. These data can thus explain the 
controversial reports that have previously overlooked the 
Figure 3: Olfactory phenotype identification by the absolute olfactory threshold frequency distribution across the 
ages of the subjects. The distribution obtained was not continuous. The fit of the distribution indicates three peaks, with R2 = 0.92, and 
a reduced Chi2 of 124.7, which are termed here as: ‘juvenile’, from frequencies range from n-butanol concentration #1 up to #3.4; ‘mature’ 
from #3.5 up to #5.9; and ‘elder’ as greater than #6.
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existence of multiple olfactory phenotypes [13, 17-20], 
which were based on the postulate that aging of olfactory 
function follows a progressive linear decline due to 
structural/ functional changes that occur to the aging nose 
and olfactory system. This also followed the common 
belief that aging is caused by random accumulation of 
molecular damage due to failure of repair [13, 20-26]. 
In contrast, olfactory aging is not a linear mechanism. 
Furthermore, this result is in line with the ‘hyper-function 
theory’ suggesting that cellular hyper-functions cause 
primary loss of homeostasis, which is the essence of aging; 
secondary are age-related diseases, for instance decline of 
functions, malfunctions, atrophy and damage, which is 
a macro event, is caused by aging, not the reverse [26]. 
The presence of these three phenotypes suggests that the 
decline of a given function, or its malfunction or damage 
(which is not molecular, but macro damage to a tissue, 
system or organ), are secondary effects of aging. 
These data were also analyzed in terms of the 
frequency distributions of the three phenotypes, which 
indicated that some young individuals showed the elder 
phenotype. This would appear to be a sign of aging and 
to represent a risk factor for decline and damage in these 
subjects, who might be highly exposed, for example, 
to neurodegenerative diseases [26]. Consequently, the 
aging of the olfactory function is crucial for the loss of 
homeostasis, and hence its onset in younger subjects 
would be predictive of earlier decline and disease.
The second main result is that the frequencies of 
these juvenile, mature and elder olfactory phenotypes 
depend on age, as about 60% of the subjects lost their 
juvenile phenotype within the third decade of life. 
Interestingly, the age-dependent normal decline of 
the olfactory phenotype starts in young individuals 
at the end of adolescence, and progressively passes 
through the subsequent phenotypes as the age of each 
subject increases, possibly in correlation with genetic 
polymorphisms, as an individual fingerprint [2, 17, 18], 
and/or due to lifestyle and environmental factors. Thus the 
statement that olfactory function decreases with aging is a 
simplistic perspective [4, 20, 25-31], as we have seen here 
that younger subjects can already show expression of the 
Figure 4: Aging of the absolute olfactory threshold phenotype. The relative levels of juvenile phenotype decreased by about 
60% within the third decade of life, contemporary with the increase to 25% of the subjects with the mature and elder phenotypes, which 
appears anticipatory of olfactory decline. From the 30 years to 60 age years clusters, the aging processes were manifest with the maximum 
expression of the mature phenotype (70% of subjects in the 50-years-old cluster), while the relative proportions of the juvenile phenotype 
decreased slowly and that of the elder phenotype started to increase, with both roughly linear during this period. For the last age clusters 
(i.e., up to 80 years old), the relative proportions of the juvenile and mature phenotypes were less than 10%, with the elder then the most 
represented phenotype ( > 90%). This indicates that the olfactory phenotype of aging can start to develop in young individuals even before 
sexual maturity. As expected, the juvenile phenotype progressively decreases as age increases.
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elder-like phenotype. 
Based on the early decline of olfactory function 
in such young subjects, we raise the hypothesis that the 
aging of olfactory functions is a dynamic process, with 
signs of elder-linked features present even at a young 
age. Indeed, olfactory dysfunction might be considered 
as an early sign of neurodegenerative disease, such as 
Alzheimer disease, even before the onset of cognitive 
decline [31-34]. Consequently, a corollary outcome is that 
young individuals with an increased frequency of the elder 
phenotype might be considered as subjects with very early 
evidence of forthcoming neurodegenerative processes.
MATERIALS AND METHODS
Sample
Six hundred and twenty two healthy individuals 
(mean age, 29.66 years ±17.1 SD; age range, 5-105 years) 
were enrolled, as representative of the Italian geographical 
spread: 256 males (mean age, 30.67 years ±18.3 SD; 
interquartile range [Q3-Q1], 25 years; age range, 5-88 
years) and 366 females (mean age, 28.95 years ±16.24 
SD; interquartile range [Q3-Q1], 14 years; age range, 
5-105 years). The exclusion criteria were smoking, 
alcohol or narcotics consumption, impaired sense of 
smell, any overt pathology or disease, or recent clinical 
surgery or anesthesia, and the use of any drugs (including 
chlorhexidine). Moreover, the additional exclusion criteria 
for the women were during their estradiol, luteinizing 
hormone and follicle-stimulating hormone peaks, or 
pregnancy or contraceptive pill use, to prevent bias due 
to these physiological and pharmacological statuses. All 
experimental procedures were clearly explained, and the 
participants or their parents provided written informed 
consent prior to the testing sessions. The participants were 
free to interrupt the testing sessions at any time. The study 
was performed in agreement with the ethical standards 
of the Helsinki Declaration 2008, and the procedure was 
approved by the local Human Review Board (n. 3135).
Study design
The experiments were performed under standardized 
conditions in a well-aired/ odorless room, without any 
bias, including laterality, and with the temperature set at 
23 °C. The olfactory stimulation was the widest used in 
similar studies, as n-butanol (C
4
H10O) and its dilutions, 
which were administered from a single sniffing point. 
The subjects were trained to report only a faint olfactory 
sensation, with no need for specific olfactory perception 
or identification, and with no somato-sensorial bias; e.g., 
pungency, itching, cooling or horripilation. A comparison 
between constant stimulation, as used here, and staircase 
stimulation was carried out initially on a random age 
sample (N = 20; 10 males; mean age, 37.9 years ±21.9 
SD; 10 females; mean age, 35.7 years ±18.9 SD).
Testing method
In the threshold tests used here, we followed the 
Cain test [9], with the n-butanol stimulus used as an 
ascending series of nine molar concentrations: (#1) 9.14 
×10-5 M; (#2) 2.74 ×10-4 M; (#3) 8.23 ×10-4 M; (#4) 2.45 
×10-3 M; (#5) 7.4 ×10-3 M; (#6) 2.20 ×10-2 M; (#7) 6.7 ×10-
2 M; (#8) 2.00 ×10-1 M; (#9) 6.00 ×10-1 M. The dilution 
medium was a sterile odorless gel (FIAB, Italy) and 
disposable vials were used for each subject and test. The 
absolute threshold detection was obtained as the mean of 
three trials in which each subject was required to stop the 
test when they could identify a faint olfactory sensation 
(i.e., the absolute olfactory threshold).
The e-nose
The volatilized n-butanol stimulus was measured 
in the real-time setting using an e-nose sensor [for 
methods, see 10-12] (iAQ-2000; AppliedSensor, Warren, 
NJ). Furthermore, the measurement of the ‘noise’ of the 
volatiles in the experimental room and of the dilution 
medium itself were both removed from the data.
Testing controls
The magnitude of the differences between the nine 
n-butanol dilutions and the measures of the volatilized 
n-butanol from the e-nose determinations were expressed 
as percentages of the ppm natural logarithm values (i.e., 
the difference values; Δ).
To validate the testing processes and the absolute 
olfactory threshold test itself, the reliability was calculated. 
The test was thus used for another random age sample (N 
= 20; mean age, 28.6 years ±4.4 SD; balanced for sex: 
10 males; mean age, 29. years 5 ±5.5 SD; 10 females; 
mean age, 27.5 years ±3.0 SD), whereby the same group 
of subjects was tested on two different days within a 30-
day maximum interval. The results of these two tests were 
compared in terms of reliability coefficient and repeated 
measures analysis of variance.
Age clustering
Following the testing process on the entire 
population, the data were clustered as age classes, with 10-
year age clustering used (up to 10 years old, 11-20 years 
old, and so on, to > 80 years old), in agreement with the 
previous literature [8, 13].
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Statistics
The data analysis was performed using the MatLab, 
Origin, SPSS software, and the data analysis and plots 
were based on dilutions #1 to #9 of the molar (M) absolute 
olfactory threshold scale. To determine the significance 
of the main effects, repeated measure ANOVA was used. 
Kolmogorov-Smirnov normality tests and non-parametric 
Kruscal-Wallis tests were used to analyze the age 
distribution of the decreased absolute olfactory threshold 
scale. 
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